YCBD

Healthcare Drug Manufacturers - Specialty & Generic

cbdMD, Inc.

$0.43

-0.02 -4.62% today

Price History

Not enough data

Key Stats

Market Cap

4.81M

Avg Volume

441,456

P/E (TTM)

1.87

EPS

$0.23

52W High

$2.56

52W Low

$0.41

Div. Yield

0.0%

Analyst Ratings

Hold

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-0.48

P/B Ratio

0.58

P/S Ratio

0.23

EV/EBITDA

-2.76

EV/Revenue

0.25

Margins

Gross Margin 57.7%

Operating Margin (20.4%)

Net Margin (13.8%)

EBITDA Margin (9.0%)

Growth & Returns

Revenue Growth (YoY)

20.6%

Return on Equity

(40.3%)

Return on Assets

(15.8%)

Liquidity & Leverage

Current Ratio

2.50

Quick Ratio

1.26

Debt / Equity

0.27

Total Cash

2.12M

Total Debt

2.21M

About

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.